Spots Global Cancer Trial Database for Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain
Official Title: A Randomized, Double-blind, Placebo-controlled Multicenter Phase II/III Study to Evaluate the Efficacy and Safety of Tegaserod and Placebo Given Orally for 12 Weeks for the Treatment of Opioid-induced Constipation (OIC) in Patients With Chronic Non-cancer Pain
Study ID: NCT00365820
Conditions
Interventions
Study Description
Brief Summary: This study will evaluate the efficacy and safety of tegaserod in opioid-induced constipation in patients with non-cancer pain.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Investigative Site, Mobile, Alabama, United States
Investigative Site, Phoenix, Arizona, United States
Investigative Site, Phoenix, Arizona, United States
Investigative Site, Tucson, Arizona, United States
Investigative Site, North Little Rock, Arkansas, United States
Investigative Site, Buena Park, California, United States
Investigative Site, Downey, California, United States
Investigative Site, Encinitas, California, United States
Investigative Site, Fountain Valley, California, United States
Investigative Site, La Jolla, California, United States
Investigative Site, Los Angeles, California, United States
Investigative Site, Mission Viejo, California, United States
Investigative Site, San Diego, California, United States
Investigative Site, San Francisco, California, United States
Investigative Site, Torrance, California, United States
Investigative Site, Northglenn, Colorado, United States
Investigative Site, Bristol, Connecticut, United States
Investigative Site, DeLand, Florida, United States
Investigative Site, Jacksonville, Florida, United States
Investigative Site, Largo, Florida, United States
Investigative Site, Miami, Florida, United States
Investigative Site, New Smyrna Beach, Florida, United States
Investigative Site, Springhill, Florida, United States
Investigative Site, Tampa, Florida, United States
Investigative Site, Belleville, Illinois, United States
Investigative Site, Chicago, Illinois, United States
Investigative Site, Avon, Indiana, United States
Investigative Site, Evansville, Indiana, United States
Investigative Site, Indianapolis, Indiana, United States
Investigative Site, Overland Park, Kansas, United States
Investigative Site, Prairie Village, Kansas, United States
Investigative Site, Shreveport, Louisiana, United States
Investigative Site, Boston, Massachusetts, United States
Investigative Site, Boston, Massachusetts, United States
Investigative Site, Omaha, Nebraska, United States
Investigative Site, Omaha, Nebraska, United States
Investigative Site, Pahrump, Nevada, United States
Novartis Pharmaceutical Corporation, East Hanover, New Jersey, United States
Investigative Site, New York City, New York, United States
Investigative Site, New York, New York, United States
Investigative Site, North Massapequa, New York, United States
Investigative Site, Charlotte, North Carolina, United States
Investigative Site, Greensboro, North Carolina, United States
Investigative Site, Monroe, North Carolina, United States
Investigative Site, Winston Salem, North Carolina, United States
Investigative Site, Dayton, Ohio, United States
Investigative Site, Oklahoma City, Oklahoma, United States
Investigative Site, Portland, Oregon, United States
Investigative Site, Hershey, Pennsylvania, United States
Investigative Site, Levittown, Pennsylvania, United States
Investigative Site, Chattanooga, Tennessee, United States
Investigative Site, Beaumont, Texas, United States
Investigative Site, Colleyville, Texas, United States
Investigative Site, Corsicana, Texas, United States
Investigative Site, Houston, Texas, United States
Investigative Site, San Antonio, Texas, United States
Investigative Site, Salt Lake City, Utah, United States
Investigative Site, Charlottesville, Virginia, United States
Investigative Site, Seattle, Washington, United States
Contact Details
Name: Novartis Pharma AG
Affiliation: Novartis Pharmaceuticals
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
